Guardian Pharmacy Services (GRDN) reported Q2 revenue up 2% YoY to $351.2M, while adjusted EBITDA rose 19% to $29.7M. The company said it continued offsetting profitability pressure tied to Inflation Reduction Act drug pricing reductions. Overall, the EBITDA improvement is a partial counter to regulatory headwinds, keeping the news modest for shares absent further guidance.
Guardian Pharmacy Services (GRDN) reported Q2 revenue up 2% YoY to $351.2M, while adjusted EBITDA rose 19% to $29.7M. The company said it continued offsetting profitability pressure tied to Inflation Reduction Act drug pricing reductions. Overall, the EBITDA improvement is a partial counter to regulatory headwinds, keeping the news modest for shares absent further guidance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
